BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25330907)

  • 1. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.
    Shih F; Yip S; McDonald PJ; Chudley AE; Del Bigio MR
    Acta Neuropathol Commun; 2014 Oct; 2():140. PubMed ID: 25330907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
    Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
    J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
    Gerami P; Paller AS
    J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
    Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
    Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic NRASopathy n a child with giant melanocytic congenital naevus, epidermal hamartoma and bilateral nephroblastomatosis: clinical implication for follow-up.
    Maridet C; Morice-Picard F; Gros A; Crivelli L; de la Fouchardière A; Vergier B; Taïeb A
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e258-e260. PubMed ID: 29314428
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
    Mitre V; Heym K; Clark GD; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
    Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
    Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric systemic lupus erythematosus in a girl with neurocutaneous melanosis caused by a somatic mutation in NRAS.
    Inoguchi T; Takenouchi T; Yamazaki F; Kondo Y; Mitamura H; Kosaki K; Takahashi T
    Rheumatology (Oxford); 2022 Aug; 61(8):e224-e226. PubMed ID: 35238342
    [No Abstract]   [Full Text] [Related]  

  • 9. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism.
    Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T
    Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRAS
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
    Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
    Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis.
    Schweizer L; Hartmann W; Koch A; Nunninger M; Thomale UW; Pennacchietti V; Tietze A; Horn D; Pajtler KW; Hirsch S; Wieland I; Deubzer H; Rossi R; Driever PH; von Hoff K; von Zezschwitz B
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12830. PubMed ID: 35728810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurocutaneous melanosis and multiple congenital melanocytic naevi are associated with post-zygotic N-ras mutations].
    Dereure O
    Ann Dermatol Venereol; 2014 Apr; 141(4):314-5. PubMed ID: 24703650
    [No Abstract]   [Full Text] [Related]  

  • 15. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
    Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
    Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Melanocytic Nevus Syndrome: A Case Series.
    Recio A; Sánchez-Moya AI; Félix V; Campos Y
    Actas Dermosifiliogr; 2017 Nov; 108(9):e57-e62. PubMed ID: 28110826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets.
    Ramesh R; Shaw N; Miles EK; Richard B; Colmenero I; Moss C
    Clin Exp Dermatol; 2017 Jan; 42(1):75-79. PubMed ID: 27900779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
    Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
    Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
    [No Abstract]   [Full Text] [Related]  

  • 19. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
    Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
    Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
    de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
    Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.